HomeCompareEMCGR vs JNJ

EMCGR vs JNJ: Dividend Comparison 2026

EMCGR yields 1923.08% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMCGR wins by $6901358465.89M in total portfolio value
10 years
EMCGR
EMCGR
● Live price
1923.08%
Share price
$0.10
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6901358465.91M
Annual income
$6,260,917,502,988,522.00
Full EMCGR calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — EMCGR vs JNJ

📍 EMCGR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMCGRJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMCGR + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EMCGR pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMCGR
Annual income on $10K today (after 15% tax)
$163,461.54/yr
After 10yr DRIP, annual income (after tax)
$5,321,779,877,540,244.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, EMCGR beats the other by $5,321,779,877,539,540.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMCGR + JNJ for your $10,000?

EMCGR: 50%JNJ: 50%
100% JNJ50/50100% EMCGR
Portfolio after 10yr
$3450679232.97M
Annual income
$3,130,458,751,494,675.00/yr
Blended yield
90.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

EMCGR
No analyst data
Altman Z
-1.8
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMCGR buys
0
JNJ buys
0
No recent congressional trades found for EMCGR or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMCGRJNJ
Forward yield1923.08%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$6901358465.91M$20.0K
Annual income after 10y$6,260,917,502,988,522.00$827.78
Total dividends collected$6855761567.51M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: EMCGR vs JNJ ($10,000, DRIP)

YearEMCGR PortfolioEMCGR Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$203,008$192,307.69$10,676$355.77+$192.3KEMCGR
2$3,865,811$3,648,592.60$11,407$389.39+$3.85MEMCGR
3$69,070,050$64,933,632.62$12,198$426.53+$69.06MEMCGR
4$1,158,169,095$1,084,264,141.28$13,056$467.62+$1158.16MEMCGR
5$18,230,811,265$16,991,570,333.10$13,987$513.12+$18230.80MEMCGR
6$269,474,592,525$249,967,624,472.06$14,998$563.56+$269474.58MEMCGR
7$3,741,458,953,337$3,453,121,139,334.48$16,098$619.52+$3741458.94MEMCGR
8$48,810,911,031,266$44,807,549,951,195.46$17,295$681.69+$48810911.01MEMCGR
9$598,542,956,001,736$546,315,281,198,281.70$18,599$750.82+$598542955.98MEMCGR
10$6,901,358,465,910,380$6,260,917,502,988,522.00$20,022$827.78+$6901358465.89MEMCGR

EMCGR vs JNJ: Complete Analysis 2026

EMCGRStock

Embrace Change Acquisition Corp. focuses on entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to pursue prospective targets that are in the technology, internet, and consumer sectors. The company was founded in 2021 and is based in San Diego, California. Embrace Change Acquisition Corp. operates as a subsidiary of Wuren Fubao Inc.

Full EMCGR Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this EMCGR vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMCGR vs SCHDEMCGR vs JEPIEMCGR vs OEMCGR vs KOEMCGR vs MAINEMCGR vs ABBVEMCGR vs MRKEMCGR vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.